Brendan Jacka1,2, Robert Kemp3, Louisa Degenhardt1, Amy Peacock1,4, Philip Clare1, Raimondo Bruno4, Abhilash Dev5, Oluwadamisola Sotade1, Briony Larance1,6. 1. National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia. 2. Kirby Institute, UNSW Sydney, Sydney, Australia. 3. Communicable Diseases Branch, Queensland Health, Brisbane, Australia. 4. School of Medicine (Psychology), University of Tasmania, Hobart, Australia. 5. Chief Medical Officer and Healthcare Regulation Branch, Queensland Health, Brisbane, Australia. 6. School of Psychology, University of Wollongong, Wollongong, Australia.
Abstract
INTRODUCTION AND AIMS: Needle-syringe programs (NSP) are an underutilized source of data on drug injection trends; these data are essential for informing public health interventions. We examine trends in NSP service occasions from 2007-2015. DESIGN AND METHODS: Using standardised data from 26 NSP outlets through the Queensland NSP Minimum Data Set (QNSPMDS), trends in service occasions among clients intending to inject methamphetamine, heroin, opioid substitution therapy (OST) medications and other pharmaceutical opioids were assessed using multilevel mixed-effects negative binomial regression, adjusting for month, year, age and clustering by site. RESULTS: Over 1.5 million service occasions were recorded in 2007-2015. Methamphetamine was the main 'drug intended to inject' (33.7%), however cf. 2007, the incidence rate ratio decreased to 0.64 (95% CI: 0.62, 0.66) in 2009, remaining low until 2015. Among clients reporting methamphetamine injection, there was a shift in the form from base to the higher-potency crystal methamphetamine since 2012. Heroin injection (22.5% service occasions) initially increased (cf. 2007), followed by a decline to 0.77 (95% CI: 0.75, 0.79) in 2015. Significant and sustained increases in OST and other pharmaceutical opioids injection were observed throughout the study period, accounting for 7.2% and 19.8% of total visits, respectively. DISCUSSION AND CONCLUSIONS: The QNSPMDS provides unique, routinely collected, jurisdiction-wide and standardised data on the demographics of people who inject drugs, types of drugs injected and regional variations; these data are essential in informing policy, planning and program implementation. There remains significant opportunity to enhance engagement and linkage to care alongside needle-syringe provision.
INTRODUCTION AND AIMS: Needle-syringe programs (NSP) are an underutilized source of data on drug injection trends; these data are essential for informing public health interventions. We examine trends in NSP service occasions from 2007-2015. DESIGN AND METHODS: Using standardised data from 26 NSP outlets through the Queensland NSP Minimum Data Set (QNSPMDS), trends in service occasions among clients intending to inject methamphetamine, heroin, opioid substitution therapy (OST) medications and other pharmaceutical opioids were assessed using multilevel mixed-effects negative binomial regression, adjusting for month, year, age and clustering by site. RESULTS: Over 1.5 million service occasions were recorded in 2007-2015. Methamphetamine was the main 'drug intended to inject' (33.7%), however cf. 2007, the incidence rate ratio decreased to 0.64 (95% CI: 0.62, 0.66) in 2009, remaining low until 2015. Among clients reporting methamphetamine injection, there was a shift in the form from base to the higher-potency crystal methamphetamine since 2012. Heroin injection (22.5% service occasions) initially increased (cf. 2007), followed by a decline to 0.77 (95% CI: 0.75, 0.79) in 2015. Significant and sustained increases in OST and other pharmaceutical opioids injection were observed throughout the study period, accounting for 7.2% and 19.8% of total visits, respectively. DISCUSSION AND CONCLUSIONS: The QNSPMDS provides unique, routinely collected, jurisdiction-wide and standardised data on the demographics of people who inject drugs, types of drugs injected and regional variations; these data are essential in informing policy, planning and program implementation. There remains significant opportunity to enhance engagement and linkage to care alongside needle-syringe provision.
Authors: Katy M E Turner; Sharon Hutchinson; Peter Vickerman; Vivian Hope; Noel Craine; Norah Palmateer; Margaret May; Avril Taylor; Daniela De Angelis; Sheila Cameron; John Parry; Margaret Lyons; David Goldberg; Elizabeth Allen; Matthew Hickman Journal: Addiction Date: 2011-08-24 Impact factor: 6.526
Authors: Foon Yin Lai; Jake W O'Brien; Phong K Thai; Wayne Hall; Gary Chan; Raimondo Bruno; Christoph Ort; Jeremy Prichard; Steve Carter; Shalona Anuj; K Paul Kirkbride; Coral Gartner; Melissa Humphries; Jochen F Mueller Journal: Sci Total Environ Date: 2016-06-17 Impact factor: 7.963
Authors: Janneke Berecki-Gisolf; Behrooz Hassani-Mahmooei; Angela Clapperton; Roderick McClure Journal: Aust N Z J Public Health Date: 2016-09-13 Impact factor: 2.939
Authors: Louisa Degenhardt; Grant Sara; Rebecca McKetin; Amanda Roxburgh; Timothy Dobbins; Michael Farrell; Lucinda Burns; Wayne D Hall Journal: Drug Alcohol Rev Date: 2016-06-11
Authors: Raimondo Bruno; Methsiri Edirisinghe; Wayne Hall; Jochen F Mueller; Foon Yin Lai; Jake W O'Brien; Phong K Thai Journal: Sci Total Environ Date: 2018-04-24 Impact factor: 7.963